BioNTech SE (BNTX) Goodwill (2018 - 2026)

BioNTech SE has reported Goodwill for 8 years, with the latest figure at $428.3 million in Q4 2025.

• Quarterly Goodwill rose 5.3% year-over-year to $428.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $428.3 million (up 5.3% YoY) and the FY2025 annual result came in at $415.7 million, up 2.2% from the prior year.
• Goodwill grew to $428.3 million in Q4 2025 per BNTX's latest filing, from $418.2 million in the prior quarter.
• Over five years, Goodwill peaked at $428.3 million in Q4 2025 and troughed at $62.4 million in Q4 2022.
• A 5-year average of $349.1 million and a median of $400.8 million in 2024 frame the typical range for Goodwill.
• The sharpest annual moves came in 2022 and 2023: Goodwill retreated 5.57% in 2022, then jumped 524.65% in 2023.
• Over 5 years, Goodwill stood at $66.1 million in 2021, then fell by 5.57% to $62.4 million in 2022, then surged by 524.65% to $390.0 million in 2023, then rose by 4.28% to $406.7 million in 2024, then climbed by 5.3% to $428.3 million in 2025.
• According to Business Quant data, Goodwill over the past three periods registered $428.3 million, $418.2 million, and $412.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.